nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—CYP1A1—Dacarbazine—sarcoma	0.293	0.601	CbGbCtD
Clenbuterol—CYP1A2—Dacarbazine—sarcoma	0.131	0.268	CbGbCtD
Clenbuterol—NGF—sciatic nerve—sarcoma	0.0996	0.589	CbGeAlD
Clenbuterol—CYP1A2—Etoposide—sarcoma	0.064	0.131	CbGbCtD
Clenbuterol—NGF—myometrium—sarcoma	0.0145	0.0857	CbGeAlD
Clenbuterol—NGF—hematopoietic system—sarcoma	0.0124	0.0736	CbGeAlD
Clenbuterol—ADRB3—connective tissue—sarcoma	0.00763	0.0451	CbGeAlD
Clenbuterol—NGF—testis—sarcoma	0.00682	0.0403	CbGeAlD
Clenbuterol—TNF—lymph node—sarcoma	0.00536	0.0317	CbGeAlD
Clenbuterol—NGF—lymph node—sarcoma	0.00495	0.0292	CbGeAlD
Clenbuterol—ADRB1—connective tissue—sarcoma	0.00312	0.0185	CbGeAlD
Clenbuterol—ADRB1—cardiac atrium—sarcoma	0.00246	0.0146	CbGeAlD
Clenbuterol—CYP1A2—hematopoietic system—sarcoma	0.00212	0.0125	CbGeAlD
Clenbuterol—CYP1A1—hematopoietic system—sarcoma	0.00209	0.0124	CbGeAlD
Clenbuterol—CYP1A1—skin of body—sarcoma	0.00182	0.0107	CbGeAlD
Clenbuterol—CYP1A1—cardiac atrium—sarcoma	0.00159	0.00939	CbGeAlD
Clenbuterol—CYP1A1—uterus—sarcoma	0.00158	0.00934	CbGeAlD
Clenbuterol—CYP1A2—liver—sarcoma	0.0011	0.00649	CbGeAlD
Clenbuterol—CYP1A1—liver—sarcoma	0.00108	0.00641	CbGeAlD
Clenbuterol—CYP1A1—lymph node—sarcoma	0.00083	0.00491	CbGeAlD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000666	0.00194	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	0.000666	0.00194	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—MDM2—sarcoma	0.000657	0.00191	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—KRAS—sarcoma	0.000649	0.00189	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	0.000641	0.00187	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MDM2—sarcoma	0.000637	0.00186	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EZR—sarcoma	0.000629	0.00183	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—HRAS—sarcoma	0.000624	0.00182	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—PDGFRB—sarcoma	0.000609	0.00177	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL2—sarcoma	0.000598	0.00174	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	0.000584	0.0017	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—sarcoma	0.00058	0.00169	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—sarcoma	0.000577	0.00168	CbGpPWpGaD
Clenbuterol—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	0.000566	0.00165	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000566	0.00165	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—JUN—sarcoma	0.000554	0.00161	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000551	0.00161	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—sarcoma	0.00055	0.0016	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCR4—sarcoma	0.000543	0.00158	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—CREB1—sarcoma	0.000543	0.00158	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000541	0.00158	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—JUN—sarcoma	0.000515	0.0015	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MYOD1—sarcoma	0.000513	0.00149	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—SRC—sarcoma	0.000512	0.00149	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—VEGFA—sarcoma	0.000508	0.00148	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000506	0.00147	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TLE1—sarcoma	0.0005	0.00146	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—sarcoma	0.000499	0.00145	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—HRAS—sarcoma	0.000498	0.00145	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000494	0.00144	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—NRAS—sarcoma	0.000493	0.00143	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000492	0.00143	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000483	0.00141	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.000474	0.00138	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000469	0.00137	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000469	0.00136	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—EGFR—sarcoma	0.000449	0.00131	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MYC—sarcoma	0.000445	0.0013	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—NRAS—sarcoma	0.000444	0.00129	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—sarcoma	0.000443	0.00129	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000442	0.00129	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000442	0.00129	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL2—sarcoma	0.000434	0.00126	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.00043	0.00125	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000425	0.00124	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—sarcoma	0.000424	0.00124	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—KRAS—sarcoma	0.000424	0.00123	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000423	0.00123	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCND1—sarcoma	0.000423	0.00123	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFC—sarcoma	0.000422	0.00123	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000414	0.00121	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000399	0.00116	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000396	0.00115	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—CTNNB1—sarcoma	0.000388	0.00113	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000387	0.00113	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000387	0.00113	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—sarcoma	0.000384	0.00112	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—KRAS—sarcoma	0.000383	0.00111	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PTPRC—sarcoma	0.000371	0.00108	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.00037	0.00108	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—sarcoma	0.000366	0.00106	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000366	0.00106	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PLCG1—sarcoma	0.000363	0.00106	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	0.000361	0.00105	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—HRAS—sarcoma	0.00036	0.00105	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MYC—sarcoma	0.000339	0.000988	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—JUN—sarcoma	0.000338	0.000983	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FLT1—sarcoma	0.000337	0.000981	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—CTNNB1—sarcoma	0.000337	0.000981	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000335	0.000976	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—EGFR—sarcoma	0.000332	0.000966	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PLCG1—sarcoma	0.000331	0.000965	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00033	0.000962	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000325	0.000947	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000323	0.000939	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCR4—sarcoma	0.000322	0.000939	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCR4—sarcoma	0.000318	0.000927	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—JUN—sarcoma	0.000318	0.000926	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCR4—sarcoma	0.000315	0.000918	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ATF1—sarcoma	0.000315	0.000916	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000314	0.000914	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000311	0.000905	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCR4—sarcoma	0.000307	0.000894	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000295	0.000859	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000288	0.000838	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000287	0.000836	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000285	0.00083	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000282	0.00082	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000282	0.00082	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR4—sarcoma	0.000279	0.000812	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—sarcoma	0.000279	0.000811	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NRAS—sarcoma	0.000275	0.000799	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000274	0.000798	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000271	0.000789	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TLE1—sarcoma	0.000259	0.000753	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000258	0.00075	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—FOXO1—sarcoma	0.000257	0.000749	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MYC—sarcoma	0.000256	0.000745	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000252	0.000735	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000251	0.00073	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—sarcoma	0.00025	0.000728	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1R—sarcoma	0.000247	0.000719	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000247	0.000719	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000247	0.000719	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—KRAS—sarcoma	0.000236	0.000688	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FOXO1—sarcoma	0.000235	0.000685	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PDGFRB—sarcoma	0.000235	0.000683	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000233	0.000679	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PDGFRA—sarcoma	0.000231	0.000673	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000231	0.000672	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000226	0.000657	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—sarcoma	0.000224	0.000652	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFC—sarcoma	0.000218	0.000635	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000213	0.000621	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KDR—sarcoma	0.000213	0.00062	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—sarcoma	0.00021	0.000612	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000198	0.000577	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KDR—sarcoma	0.000194	0.000566	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00019	0.000552	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CREB1—sarcoma	0.000187	0.000544	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR4—sarcoma	0.000182	0.000531	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KIT—sarcoma	0.000179	0.000522	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR4—sarcoma	0.000178	0.000519	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FLT1—sarcoma	0.000174	0.000508	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—sarcoma	0.000174	0.000506	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PLCG1—sarcoma	0.000171	0.000499	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CREB1—sarcoma	0.000171	0.000496	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR4—sarcoma	0.000165	0.000482	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR4—sarcoma	0.000165	0.00048	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ATF1—sarcoma	0.000163	0.000474	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR4—sarcoma	0.000162	0.000471	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TLE1—sarcoma	0.000153	0.000447	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TLE1—sarcoma	0.00015	0.000437	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CREB1—sarcoma	0.000149	0.000435	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MDM2—sarcoma	0.000141	0.000411	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CTNNB1—sarcoma	0.000133	0.000388	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFC—sarcoma	0.000129	0.000377	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1R—sarcoma	0.000128	0.000372	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFC—sarcoma	0.000127	0.000369	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—sarcoma	0.000126	0.000367	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCND1—sarcoma	0.000123	0.000358	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JUN—sarcoma	0.000123	0.000357	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CTNNB1—sarcoma	0.000122	0.000354	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FOXO1—sarcoma	0.000122	0.000354	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—sarcoma	0.000122	0.000354	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PDGFRB—sarcoma	0.000121	0.000354	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—SRC—sarcoma	0.00012	0.000351	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PDGFRA—sarcoma	0.00012	0.000348	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—sarcoma	0.000117	0.000342	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NRAS—sarcoma	0.000116	0.000337	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—sarcoma	0.00011	0.000321	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SRC—sarcoma	0.00011	0.00032	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—sarcoma	0.000107	0.000312	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NRAS—sarcoma	0.000106	0.000308	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—sarcoma	0.000106	0.000307	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FLT1—sarcoma	0.000104	0.000301	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PLCG1—sarcoma	0.000102	0.000296	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FLT1—sarcoma	0.000101	0.000295	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KDR—sarcoma	0.000101	0.000293	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—sarcoma	9.97e-05	0.00029	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PLCG1—sarcoma	9.95e-05	0.00029	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—sarcoma	9.86e-05	0.000287	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR4—sarcoma	9.77e-05	0.000285	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ATF1—sarcoma	9.67e-05	0.000281	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—sarcoma	9.64e-05	0.000281	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR4—sarcoma	9.56e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ATF1—sarcoma	9.45e-05	0.000275	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ENO2—sarcoma	9.33e-05	0.000272	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HBA1—sarcoma	9.27e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KIT—sarcoma	9.27e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—NRAS—sarcoma	9.27e-05	0.00027	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—sarcoma	9.11e-05	0.000265	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CREB1—sarcoma	8.86e-05	0.000258	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CREB1—sarcoma	8.82e-05	0.000257	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CREB1—sarcoma	8.67e-05	0.000252	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—sarcoma	8.48e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—sarcoma	8.44e-05	0.000246	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—sarcoma	8.09e-05	0.000236	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—sarcoma	7.98e-05	0.000232	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLCG1—sarcoma	7.92e-05	0.000231	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—sarcoma	7.74e-05	0.000225	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1R—sarcoma	7.58e-05	0.000221	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1R—sarcoma	7.42e-05	0.000216	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—sarcoma	7.3e-05	0.000213	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FOXO1—sarcoma	7.22e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—sarcoma	7.22e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFRB—sarcoma	7.21e-05	0.00021	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFRA—sarcoma	7.09e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FOXO1—sarcoma	7.06e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—sarcoma	7.06e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFRB—sarcoma	7.05e-05	0.000205	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFRA—sarcoma	6.94e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—sarcoma	6.78e-05	0.000197	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—sarcoma	6.55e-05	0.000191	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—sarcoma	6.52e-05	0.00019	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—sarcoma	6.41e-05	0.000187	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—sarcoma	6.36e-05	0.000185	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JUN—sarcoma	6.34e-05	0.000185	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CTNNB1—sarcoma	6.3e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—sarcoma	5.97e-05	0.000174	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO2—sarcoma	5.95e-05	0.000173	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HBA1—sarcoma	5.91e-05	0.000172	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—sarcoma	5.84e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SRC—sarcoma	5.69e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—sarcoma	5.54e-05	0.000161	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KIT—sarcoma	5.5e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NRAS—sarcoma	5.5e-05	0.00016	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRAS—sarcoma	5.47e-05	0.000159	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KIT—sarcoma	5.38e-05	0.000157	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NRAS—sarcoma	5.38e-05	0.000157	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CREB1—sarcoma	5.24e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CREB1—sarcoma	5.12e-05	0.000149	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—sarcoma	5.1e-05	0.000148	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLCG1—sarcoma	5.05e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—sarcoma	5.01e-05	0.000146	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—sarcoma	4.99e-05	0.000145	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—sarcoma	4.9e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—sarcoma	4.73e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—sarcoma	4.71e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—sarcoma	4.63e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—sarcoma	4.33e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—sarcoma	4.24e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—sarcoma	4.19e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—sarcoma	4.02e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—sarcoma	4.01e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—sarcoma	3.94e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—sarcoma	3.87e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—sarcoma	3.79e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—sarcoma	3.77e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JUN—sarcoma	3.77e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CTNNB1—sarcoma	3.74e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—sarcoma	3.69e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JUN—sarcoma	3.68e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CTNNB1—sarcoma	3.66e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SRC—sarcoma	3.38e-05	9.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SRC—sarcoma	3.3e-05	9.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—sarcoma	3.29e-05	9.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRAS—sarcoma	3.25e-05	9.46e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—sarcoma	3.22e-05	9.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRAS—sarcoma	3.18e-05	9.26e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—sarcoma	3.03e-05	8.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—sarcoma	2.96e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—sarcoma	2.96e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—sarcoma	2.9e-05	8.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—sarcoma	2.8e-05	8.14e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—sarcoma	2.74e-05	7.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—sarcoma	2.49e-05	7.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—sarcoma	2.43e-05	7.08e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—sarcoma	2.38e-05	6.92e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—sarcoma	2.33e-05	6.77e-05	CbGpPWpGaD
